openPR Logo
Press release

Fibrinogen market size becomes USD 2133.3 million by 2029 with a CAGR of 14.6% during 2023-2029

04-15-2024 03:04 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Quants and Trends

Fibrinogen market

Fibrinogen market

The global Fibrinogen market size was valued at USD 819.7 million in 2022 and is forecast to a readjusted size of USD 2133.3 million by 2029 with a CAGR of 14.6% during review period. The global fibrinogen market has witnessed significant growth in recent years, driven by advancements in healthcare technology, increasing prevalence of chronic diseases, and rising demand for fibrinogen-based products across various medical applications. This press release aims to provide a comprehensive overview of the fibrinogen market, including key players, market segmentation, regional analysis, market strengths, weaknesses, opportunities, threats, past performance, forecast, research and development activities, and analytical frameworks such as PESTEL and SIPOC.

Market Overview:
Fibrinogen, a vital blood clotting protein, plays a crucial role in hemostasis and wound healing. The fibrinogen market encompasses various products derived from human plasma, including fibrinogen concentrates, cryoprecipitate, and fibrin sealants. These products find extensive applications in surgical procedures, trauma management, and treatment of rare bleeding disorders.
Global core fibrinogen manufacturers include CSL Behring, LFB Group and Shanghai RAAS Blood Products etc. The top company hold a share about 52%. North America is the largest market, with a share about 31%, followed by Europe and Asia Pacific with the share about 28% and 26%.

Market Key Players:
• CSL Behring
• LFB Group
• Shanghai RAAS Blood Products
• Jiangxi Boya Bio-Pharmaceutical
• Hualan Biological Engineering
• Harbin Pacific Biopharmaceutical
• Shanghai XinXing Medical
• Taibang Biologic
• Octapharma


Market Segmentation by Type:
• Human Fibrinogen
• Animal Fibrinogen

Market Segmentation by Application:
• Congenital Fibrinogen Deficiency
• Surgical Procedures
• Others

US Market:
The United States accounts for a significant share of the global fibrinogen market, driven by the high prevalence of cardiovascular diseases, increasing surgical procedures, and robust healthcare infrastructure supporting the adoption of advanced fibrinogen-based therapies.

EUROPE Market:
Europe is a key region in the fibrinogen market, characterized by a growing elderly population, rising healthcare expenditure, and favorable reimbursement policies for plasma-derived products.

APAC Market:
The Asia-Pacific region exhibits immense growth potential in the fibrinogen market, attributed to the increasing incidence of trauma cases, improving healthcare infrastructure, and expanding awareness about bleeding disorders.

Middle-East Market:
The Middle East region is witnessing steady growth in the fibrinogen market, supported by government initiatives to enhance healthcare infrastructure and rising investments in research and development activities.

Market Segmentation by Regions:
• North America (United States, Canada and Mexico)
• Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
• Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
• South America (Brazil, Argentina, Colombia, and Rest of South America)
• Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

For Exhaustive Table of Contents and Tables and Figures, please visit @

Market Strengths:
Key strengths of the fibrinogen market include growing demand for plasma-derived therapies, expanding applications in surgical procedures, and increasing investments in research and development for novel fibrinogen-based products.

Market Weaknesses:
Challenges facing the fibrinogen market include stringent regulatory requirements for plasma-derived products, limited availability of plasma donors, and concerns regarding the transmission of infectious diseases.

Market Opportunities:
Opportunities in the fibrinogen market lie in the development of recombinant fibrinogen products, expansion of product portfolios by key players, and strategic collaborations for product commercialization in emerging markets.

Market Threats:
Threats to the fibrinogen market include pricing pressures, competition from alternative hemostatic agents, and the emergence of substitutes such as synthetic fibrinogen analogs.

Market Past Performance:
The fibrinogen market has demonstrated steady growth over the past decade, fueled by increasing healthcare expenditure, advancements in biotechnology, and rising awareness about bleeding disorders.

Market Forecast:
The global fibrinogen market is projected to witness robust growth in the coming years, driven by the rising prevalence of cardiovascular diseases, growing demand for fibrinogen-based therapies, and expanding applications in trauma management and surgical procedures.

Market Research and Development:
Ongoing research and development efforts focus on developing novel fibrinogen-based therapies with improved efficacy, safety, and ease of administration. Key areas of research include recombinant fibrinogen, fibrinogen mimetics, and gene therapy approaches.

Market PESTEL Analysis:
A PESTEL analysis of the fibrinogen market reveals key factors influencing its growth, including political stability, economic trends, socio-cultural factors, technological advancements, environmental regulations, and legal frameworks governing plasma-derived products.

Market SIPOC Analysis:
A SIPOC (Suppliers, Inputs, Process, Outputs, Customers) analysis of the fibrinogen market elucidates the key stakeholders involved in the value chain, from plasma donors and manufacturers to healthcare providers and patients.

In conclusion, the global fibrinogen market is poised for significant growth, driven by increasing healthcare expenditure, rising prevalence of bleeding disorders, and expanding applications in surgical procedures and trauma management. Key players are leveraging advancements in biotechnology to develop innovative fibrinogen-based therapies, thereby enhancing patient outcomes and driving market expansion. Despite challenges and uncertainties, the future outlook for the fibrinogen market remains promising, with ample opportunities for innovation and growth.

For further inquiries, please contact:
US: +1-315-675-4303
INDIA: +91-952-980-3362
Sector-13, Chikhali Pradhikaran,
Pune-411019, Maharashtra, India.

About Quants and Trends:
Through our consulting research solutions, we guide our clients in discovering answers to their research needs. We pledge to offer our clients only the best research and consulting services. With our low-cost market research services, we assist our clients in understanding the major industry trends, spotting opportunities, and coming to wise conclusions. We understand not every client's particular research needs may be satisfied by syndicated papers. We offer our dear clients with an array of options to tailor research to meet their unique objectives and financial constraints.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Fibrinogen market size becomes USD 2133.3 million by 2029 with a CAGR of 14.6% during 2023-2029 here

News-ID: 3464347 • Views:

More Releases from Quants and Trends

Shape Memory Alloys Market Size Worth USD 1385.4 Million by 2029 at a CAGR of 8.2% during review period 2023-2029
Shape Memory Alloys Market Size Worth USD 1385.4 Million by 2029 at a CAGR of 8. …
The global Shape Memory Alloys Market size was valued at USD 796.4 million in 2022 and is forecast to a readjusted size of USD 1385.4 million by 2029 with a CAGR of 8.2% during review period. Market Overview: Shape Memory Alloys (SMAs) are revolutionary materials with the unique ability to return to a predetermined shape when subjected to certain stimuli, such as temperature or stress. This remarkable property has led to their
Electroless Plating Market Worth USD 5469.7 Million by 2029 at a CAGR of 3.0% during review period 2023-2029
Electroless Plating Market Worth USD 5469.7 Million by 2029 at a CAGR of 3.0% du …
The global Electroless Plating Market size was valued at USD 4457.4 million in 2022 and is forecast to a readjusted size of USD 5469.7 million by 2029 with a CAGR of 3.0% during review period. Market Overview: Electroless plating, also known as autocatalytic plating, is a chemical process that deposits a metal or alloy onto a substrate without the use of an external electrical power source. This method offers several advantages, including
Braze Market Size Worth USD 5563.3 Million by 2029 at a CAGR of 1.8% during review period 2023-2029
Braze Market Size Worth USD 5563.3 Million by 2029 at a CAGR of 1.8% during revi …
The global Braze Market size was valued at USD 4904 million in 2022 and is forecast to a readjusted size of USD 5563.3 million by 2029 with a CAGR of 1.8% during review period. Market Overview: The Braze Market plays a pivotal role in various industries, offering a reliable method for joining metal components with superior strength and durability. Brazing involves the use of a filler metal that melts above 450°C (840°F)
Re-dispersible Latex Powder (RDP) Market Worth USD 1935.3 Million by 2029 at a CAGR of 3.2% during review period 2023-2029
Re-dispersible Latex Powder (RDP) Market Worth USD 1935.3 Million by 2029 at a C …
The global Re-dispersible Latex Powder (RDP) Market size was valued at USD 1556.8 million in 2022 and is forecast to a readjusted size of USD 1935.3 million by 2029 with a CAGR of 3.2% during review period. Market Overview: Re-dispersible latex powder (RDP) is a crucial additive used in construction materials such as mortars, plasters, and tile adhesives. It enhances the performance of these materials by imparting properties such as improved adhesion,

All 5 Releases

More Releases for Fibrinogen

Fibrinogen Concentrate Market 2022 | Detailed Report
According to Market Study Report, Fibrinogen Concentrate Market provides a comprehensive analysis of the Fibrinogen Concentrate Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in this report is collected by research and industry experts team. Download FREE Sample Report @ The report provides a comprehensive analysis of company profiles listed below: - CSL Behring - LFB - Shanghai RAAS - Boya -
Human Fibrinogen Market Exponential Growth by 2027 with Congenital Fibrinogen De …
Fibrinogen is an acute-phase protein that is part of the coagulation cascade and is converted into the insoluble protein fibrin during the clotting process. The activated thrombin or Factor II converts fibrinogen to fibrin in response to bleeding. The normal concentration of fibrinogen in blood plasma is 150–400 mg/dl, with levels appreciably below or above this range associated with pathological bleeding and/or thrombosis. Fibrinogen, or factor I, is a blood
Human Fibrinogen Market to Witness an Outstanding Growth by 2027| Congenital Fib …
LOS ANGELES, UNITED STATES - The report comes out as an intelligent and thorough assessment tool as well as a great resource that will help you to secure a position of strength in the global Human Fibrinogen market. It includes Porter’s Five Forces and PESTLE analysis to equip your business with critical information and comparative data about the Global Human Fibrinogen Market. We have provided deep analysis of the vendor
Global Fibrinogen Concentrates Market Insights, Forecast to (2018-2025)|Key Play …
The global market status for Fibrinogen Concentrates is precisely examined through a smart research report added to the broad database managed by Market Research Hub (MRH). This study is titled “Global Fibrinogen Concentrates Market Insights, Forecast to 2025which tends to deliver in-depth knowledge associated to the Fibrinogen Concentrates market for the present and forecasted period until “2025”. Furthermore, the report examines the target market based on market size, revenue and
Human Fibrinogen Market Report 2018: Segmentation by Type (Pure Human Fibrinogen …
Global Human Fibrinogen market research report provides company profile for Hualan Biological Engineering, Harbin Pacific Biopharmaceutical, Greencross, Shanghai XinXing Medical, CSL Behring, LFB, Shanghai RAAS, Boya and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025,
Fibrinogen Market 2018 Trends and Opportunities 2025 has announced the addition of the “Global Fibrinogen Market Research Report 2018” report detailed insights about the aspects responsible for augmenting as well as restraining market growth and analyses the market potential for each geographical region based on the growth rate, macroeconomic parameters, consumer buying patterns, and market demand and supply scenarios. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), and market share